Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Yu-ichiro Azuma"'
Autor:
Tadaaki Hanatani, H. Omatsu, Katsunori Segawa, Kimie Sai, H. Makimoto, Masahiro Tohkin, Midori Hirai, Yu-ichiro Azuma, Yoshiro Saito
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 38:230-235
SummaryWhat is known and Objective Demonstration of the utility of electronic medical records (EMRs) for pharmacovigilance (PV) has been highly anticipated. Analysis using appropriately selected EMRs should enable accurate estimation of adverse drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48257af8638130a2fcd331d66a798bbf
https://doi.org/10.1111/jcpt.12063
https://doi.org/10.1111/jcpt.12063
Autor:
Yu-ichiro Azuma, Nobuaki Yokote, Hiroshi Yamamoto, Yoshinori Makino, Akihiro Hirakawa, Kimie Sai, Masahiro Tohkin, Norifumi Morikawa, Yoshiro Saito, Yasuhiro Fujiwara, Ryoko Udagawa, Kojiro Hata, Yasuaki Ryushima
Publikováno v:
Biologicalpharmaceutical bulletin. 35(5)
Capecitabine, an oral prodrug of 5-fluorouracil (5-FU), is a promising treatment for colorectal, breast and gastric cancers, but often causes hand-foot syndrome (HFS), the most common dose-limiting toxicity. The current study was conducted to investi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb3007ac5ceecad7e8c058c2c3270f86
https://pubmed.ncbi.nlm.nih.gov/22687407
https://pubmed.ncbi.nlm.nih.gov/22687407
Publikováno v:
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo hokoku = Bulletin of National Institute of Health Sciences. (129)
Spontaneous reports on suspected serious adverse events caused by medicines from manufacturing/distributing pharmaceutical companies or medical institutions/pharmacies are regulated by the Pharmaceutical Affairs Law of Japan, and this system is impor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9c2bbffdd06d85dc9618c8f803cedea6
https://pubmed.ncbi.nlm.nih.gov/22259851
https://pubmed.ncbi.nlm.nih.gov/22259851